Dashboard
Manage Tickers

AIMTAimmune Therapeutics, Inc.

Nasdaq www.aimmune.com


$ 34.50 $ -0.10 (-0.29 %)    

Monday, 12-Oct-2020 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 451.63 $ -0.22 (-0.05 %)
DIA $ 399.76 $ 0.74 (0.19 %)
SPY $ 529.24 $ 0.76 (0.14 %)
TLT $ 91.40 $ -0.62 (-0.67 %)
GLD $ 223.63 $ 3.63 (1.65 %)
$ 34.49
$ 34.49 x 300
$ 34.51 x 300
-- - --
$ 10.09 - $ 37.00
969,191
na
2.26B
$ 0.87
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-31-2020 06-30-2020 10-Q
2 05-11-2020 03-31-2020 10-Q
3 02-27-2020 12-31-2019 10-K
4 11-06-2019 09-30-2019 10-Q
5 08-08-2019 06-30-2019 10-Q
6 05-08-2019 03-31-2019 10-Q
7 02-28-2019 12-31-2018 10-K
8 11-08-2018 09-30-2018 10-Q
9 08-08-2018 06-30-2018 10-Q
10 05-08-2018 03-31-2018 10-Q
11 02-20-2018 12-31-2017 10-K
12 11-06-2017 09-30-2017 10-Q
13 08-08-2017 06-30-2017 10-Q
14 05-08-2017 03-31-2017 10-Q
15 03-15-2017 12-31-2016 10-K
16 11-14-2016 09-30-2016 10-Q
17 08-10-2016 06-30-2016 10-Q
18 05-16-2016 03-31-2016 10-Q
19 03-03-2016 12-31-2015 10-K
20 11-04-2015 09-30-2015 10-Q
21 08-31-2015 06-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Benzinga's Top Upgrades, Downgrades For Se...
09/01/2020 13:47:33

Upgrades

credit-suisse-maintains-neutral-on-aimmune-therapeutics-raises-price-target-to-345
Credit Suisse Maintains Neutral on Aimmune...
09/01/2020 12:32:42

Credit Suisse analyst Evan Seigerman maintains Aimmune Therapeutics (NASDAQ:AIMT) with a Neutral and raises the price targe...

10-biggest-price-target-changes-for-tuesday
10 Biggest Price Target Changes For Tuesday
09/01/2020 12:06:43

Goldman Sachs raised the price target for Zoom Video Communications Inc (NASDAQ: ZM) from $187 to $402. Zoom Video shares r...

cantor-fitzgerald-downgrades-aimmune-therapeutics-to-neutral-raises-price-target-to-35
Cantor Fitzgerald Downgrades Aimmune Thera...
09/01/2020 10:19:28

Cantor Fitzgerald downgrades Aimmune Therapeutics (NASDAQ:AIMT) from Overweight to Neutral and raises the price target from $...

wedbush-downgrades-aimmune-therapeutics-to-neutral-lowers-price-target-to-345
Wedbush Downgrades Aimmune Therapeutics to...
09/01/2020 09:45:53

Wedbush analyst Liana Moussatos downgrades Aimmune Therapeutics (NASDAQ:AIMT) from Outperform to Neutral and lowers the pric...

60-biggest-movers-from-yesterday
60 Biggest Movers From Yesterday
09/01/2020 09:07:39

Gainers Aimmune Therapeutics, Inc (NASDAQ: AIMT) shares jumped 171.6% to close at $34.22 on Monday after Nestle SA agreed to...

hearing-wedbush-downgrades-aimmune-from-outperform-to-neutral
Hearing Wedbush Downgrades Aimmune From Ou...
08/31/2020 20:38:20

-Reuters

Core News & Articles
Mid-Afternoon Market Update: Nasdaq Rises ...
08/31/2020 18:30:24

Toward the end of trading Monday, the Dow traded down 0.72% to 28446.24 while the NASDAQ rose 1% to 11,812.92. The S&P also...

Core News & Articles
50 Stocks Moving In Monday's Mid-Day Session
08/31/2020 16:11:49

Gainers Aimmune Therapeutics, Inc (NASDAQ: AIMT) shares climbed 171.5% to $34.21 after Nestle SA agreed to acquire the compa...

Core News & Articles
Mid-Day Market Update: Akcea Therapeutics ...
08/31/2020 16:04:26

Midway through trading Monday, the Dow traded down 0.94% to 28385.03 while the NASDAQ rose 0.23% to 11722.14. The S&P also ...

piper-sandler-downgrades-aimmune-therapeutics-to-neutral-lowers-price-target-to-345
Piper Sandler Downgrades Aimmune Therapeut...
08/31/2020 15:32:44

Piper Sandler analyst Christopher Raymond downgrades Aimmune Therapeutics (NASDAQ:AIMT) from Overweight to Neutral and lower...

Core News & Articles
Mid-Morning Market Update: Markets Mostly ...
08/31/2020 14:10:18

Following the market opening Monday, the Dow traded down 0.60% to 28483.09 while the NASDAQ rose 0.26% to 11,725.76. The S&...

roce-insights-for-aimmune-therapeutics
ROCE Insights For Aimmune Therapeutics
08/31/2020 12:44:43

During Q2, Aimmune Therapeutics (NASDAQ: AIMT) brought in sales totaling $0.00. However, earnings decreased 22.62%, resulting i...

38-stocks-moving-in-mondays-pre-market-session
38 Stocks Moving in Monday's Pre-Market Se...
08/31/2020 11:02:16

Gainers Aimmune Therapeutics, Inc (NASDAQ: AIMT) shares rose 169.8% to $34.00 in pre-market trading after Nestle SA agreed t...

a-peek-into-the-markets-us-stock-futures-gain-ahead-of-zoom-earnings
A Peek Into The Markets: US Stock Futures ...
08/31/2020 10:05:45

Pre-open movers

Core News & Articles
Nestlé to acquire Aimmune Therapeutics for...
08/31/2020 09:30:29

Nestlé (OTC:NSTRF) and Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing and commercializing tr...

aimmune-shares-surge-170-as-nestle-set-to-acquire-company-at-26b-enterprise-value
Aimmune Shares Surge 170% As Nestle Set To...
08/31/2020 08:40:38

Nestle S.A. (OTC: NSRGY) subsidiary Nestle Health Sciences (NHSc) is aquiring biopharma company Aimmune Therapeutics, Inc.

aim-immunotech-says-decreases-sars-cov-2-infectious-viral-yields-by-90-using-new-in-vitro-model-says-supports-further-testing-of-ampligen-as-an-intranasal-prophylactic-to-prevent-covid-19
AIM ImmunoTech Says Decreases SARS-CoV-2 I...
08/27/2020 13:17:07

aimmune-therapeutics-highlights-appeal-2-study-in-peanut-allergy
Aimmune Therapeutics Highlights APPEAL-2 S...
08/24/2020 12:41:00

Aimmune Therapeutics, Inc. (NASDAQ:AIMT), a biopharmaceutical company developing and commercializing treatments for potentially...

why-shares-of-aimmune-are-trading-higher-while-dbv-plunges
Why Shares of Aimmune Are Trading Higher W...
08/04/2020 15:05:34

Aimmune Therapeutics Inc (NASDAQ: AIMT) shares, which recovered Monday following an earnings-induced sell-off Friday, are addin...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION